HepaRank – a comprehensive report on liver health

🧪📢 We have launched HepaRank – an advanced liver bioprognostic test designed for the non-invasive assessment of liver damage risk.

It is more than a standard liver test panel. HepaRank combines 10 blood biomarkers with patient clinical data including age, sex, weight, height, and BMI, generating a comprehensive algorithm-based report on liver health.

The test provides separate scores for assessing the risk of ↓

📄 liver fibrosis (F0–F4) – the degree of liver scarring and tissue stiffening
📄 hepatic steatosis (S0–S3) – fat accumulation in the liver
📄 viral inflammation/necroinflammatory liver activity (V0–V3) – signs of inflammation in chronic hepatitis C or B infection
📄 metabolic inflammation/metabolic liver injury (M0–M2) – associated with diabetes mellitus, obesity, dyslipidemia, and metabolic syndrome
📄 a pattern compatible with alcohol-related liver injury (E0–E3) – assessment of inflammation in cases of possible alcohol consumption

Important ❕
HepaRank does not establish a diagnosis on its own and does not replace medical consultation, liver ultrasound, liver elastography, or specific etiological tests. The results should be interpreted by a physician within the clinical context.

🩸 The test is performed using a venous blood sample obtained through a simple blood draw.

Contact us ↓

🤳 via our InvitroZen app
🔎 here on our website
💬 078 903 999 by message or phone call